Chronic forms of major depression are still undertreated in the 21st century: Systematic assessment of 801 patients presenting for treatment

Journal of Affective Disorders

Volumn 110, Issue 1-2, 2008, Pages 55-61

  Kocsis, James H ^a   Gelenberg, Alan J ⁱ   Rothbaum, Barbara ^b   Klein, Daniel N ^c   Trivedi, Madhukar H ^d   Manber, Rachel ^e   Keller, Martin B ^f   Howland, Robert ^g   Thase, Michael E ^h  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e STANFORD UNIVERSITY   (United States)

^f BROWN UNIVERSITY   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ Health System   (United States)

Author keywords

Chronic; Depression; Pharmacotherapy; Treatment

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; VENLAFAXINE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; MELANCHOLIA; PRIORITY JOURNAL; PSYCHOTHERAPY; RATING SCALE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MARITAL STATUS; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF HEALTH CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 47749133086     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.01.002     Document Type: Article

References (23)

1. Bollini P., Pampallona S., Tibaldi G., Kupelnick B., and Munizza C. Effectiveness of antidepressants. Meta-analysis of dose-effect relationships in randomised clinical trials. Br. J. Psychiatry 174 (1999) 297-303
2. Charbonneau A., Rosen A.K., Ash A.S., Owen R.R., Kader B., Spiro III A., Hankin C., Herz L.R., Jo V., Pugh M., Kazis L., Miller D.R., and Berlowitz D.R. Measuring the quality of depression care in a large integrated health system. Med. Care 41 (2003) 669-680
3. Crismon M.L., Trivedi M.H., Pigott T.A., Rush A.J., Hirschfeld R.M.A., Kahn D.A., DeBattista C., Nelson C.J., Nierenberg A.A., Sackeim H.A., and Thase M.E. The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J. Clin. Psychiatry 60 (1999) 142-156
4. First M.B., Spitzer R.L., Gibbon M., et al. Structured clinical interview axis-I DSM-IV disorders. Patient Edition (SCID-II, Version 2.0) (1994), Biometrics Research Dept., New York State Psychiatric Institute
5. Furukawa T.A., McGuire H., and Barbui C. Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ 325 (2002) 991-995
6. Guy W. ECDEU assessment manual for psychopharmacology. Department of Health, Education and Welfare Publication No. (ADM) (1976) 76-338
7. Hamilton M. Development of a rating scale for primary depressive illness. Brit. J. Soc. Clin. Psychol., 6 (1967) 278-296
8. Hirschfeld R.M., Keller M.B., Panico S., Arons B.S., Barlow D., Davidoff F., Endicott J., Froom J., Goldstein M., Gorman J.M., Marek R.G., Maurer T.A., Meyer R., Phillips K., Ross J., Schwenk T.L., Sharfstein S.S., Thase M.E., and Wyatt R.J. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277 (1997) 333-340
9. Keller M.B. Undertreatment of major depression. Psychopharmacol. Bull. 24 (1988) 75-80
10. Keller M.B., Harrison W., Fawcett J.A., Gelenberg A.J., Hirschfeld R.M.A., Klein D.N., Kocsis J.H., et al. Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol. Bull. 31 (1995) 205-212
11. Keller M.B., Gelenberg A.J., Hirschfeld R.M.A., Rush A.J., Thase M.E., Kocsis J.H., Markowitz J.C., Fawcett J.A., Koran C.M., Klein D.N., Rusell J.M., Kornstein S.G., McCullough J.P., Davis S.M., and Harrison W.M. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J. Clin. Psychiatry 59 (1998) 598-607
12. Keller M.B., McCullough J.P., Klein D.N., Arnow B., Dunner D.L., Gelenberg A.J., Markowitz J., Nemeroff C.B., Russell J.M., Thase M.E., Trivedi M., and Zajecka J. A comparison of nefazodone, the cognitive behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. NEJM 342 (2000) 1462-1470
13. Kessler R.C., Bergland P., Demler O., Jin R., Koretz D., Marikangas K.R., Rush A.J., Walters E.E., and Wang P.S. The epidemiology of major depressive disorder: evidence from the national comorbidity survey replication (NCS-R). JAMA 289 (2003) 3095-3105
14. Markowitz J.C., Kocsis J.H., Bleiberg K.L., Christos P.J., and Sacks M.H. A comparative trial of psychotherapy and pharmacotherapy for "pure" dysthymic patients. J. Affect. Disord. 89 (2005) 167-175
15. McCullough J.P. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy (2000), Guilford Press, New York
16. Oquendo M.A., Malone K.M., Ellis S.P., Sackeim H.A., and Mann J.J. Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior. Am. J. Psychiatry 156 (1999) 190-194
17. Oquendo M.A., Kamali M., Ellis S.P., Grunebaum M.F., Malone K.M., Brodsky B.S., Sackeim H.A., and Mann J.J. Adequacy of antidepressant treatment after discharge and the occurrence of suicidal acts in major depression: a prospective study. Am. J. Psychiatry 159 (2002) 1746-1751
18. Rasmussen K.G., Mueller M., Kellner C.H., Knapp R.G., Petrides G., Rummans T.A., Husain M.M., O'connor M.K., Black J.L., Sampson S., Fink M., and CORE group. Patterns of psychotropic medication use among patients with severe depression referred for electroconvulsive therapy: data from the consortium for research on electroconvulsive therapy. J. ECT 22 (2006) 116-123
19. Ruhe H.G., Huyser J., Swinkels J.A., and Schene A.H. Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: systematic review. Br. J. Psychiatry 189 (2006) 309-316
20. Rush A.J., Giles D.E., Schlesser M.A., Fulton C.L., Weissenburger J., and Burns C. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res. 18 (1986) 65-87
21. Sackeim H.A., Prudic J., Devanand D.P., Decina P., Kerr B., and Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J. Clin. Psychopharmacol. 10 (1990) 96-104
22. Thase M.E., Fava M., Halbreich U., Kocsis J.H., Koran L., Davidson J., Rosenbaum J., and Harrison W. A placebo-controlled randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch. Gen. Psychiatry. 53 (1996) 777-784
23. Weilburg J.B., O'Leary K.M., Meigs J.B., Hennen J., and Stafford R.S. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr. Serv. 54 (2003) 1233-1239